ATRS
Antares Pharma, Inc.
ATRS
ATRS
Delisted
ATRS was delisted on the 23rd of May, 2022.
85 hedge funds and large institutions have $142M invested in Antares Pharma, Inc. in 2017 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 24 increasing their positions, 13 reducing their positions, and 5 closing their positions.
Holders
85
Holders Change
+14
Holders Change %
+19.72%
% of All Funds
2.12%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
23
Increased
24
Reduced
13
Closed
5
Calls
$372K
Puts
$130K
Net Calls
+$242K
Net Calls Change
+$176K
Top Buyers
| 1 |
1
BlackRock
New York
|
$8.22M |
| 2 |
2
Millennium Management
New York
|
$6.2M |
| 3 |
RCMNY
3
Rubric Capital Management (New York)
New York
|
$6.74M |
| 4 |
4
Morgan Stanley
New York
|
$2.83M |
| 5 |
5
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$1.97M |
